Polaris Partners

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With a focus on technology and healthcare sectors, Polaris invests in companies at all stages of development, from inception to profitable growth. The firm has a history of partnering with experienced entrepreneurs and innovators, aiming to enhance the way people live and work. In addition to its Boston headquarters, Polaris has offices in San Francisco and New York, and it actively targets investments in life sciences, biotechnology, and software industries across the United States and Europe. Over its more than two-decade history, Polaris Partners has established itself as a multibillion-dollar investment firm committed to fostering innovation and entrepreneurship.

Stephen D. Arnold

Co-Founder and Partner Emeritus

David Barrett

Partner

Dave Barrett

Managing Partner

Marissa Bertorelli

Principal

Jack Burke

Associate

Alexandra Cantley

Partner

Darren Carroll

Managing Partner

Brian Chee

Managing Partner

Isaac Ciechanover

Partner

George Conrades

Venture Partner, Venture Partner Emeritus and Partner Emeritus

Peter A. Flint

Venture Partner

Jon Flint

Founding Partner

Jason Franklyn

Associate

Harold Friedman

Chief Financial Officer

Brendan Hannigan

Entrepreneur Partner

Mark Jacobson

Principal

Rahul Kakkar

Entrepreneur Partner

Timothy J. Kilgallon

CEO-in-Residence

Dan Lombard

Partner

Ellie McGuire

Partner

Terry McGuire

Founding Partner

Sabrina McLaughry

Principal

Robert M. Metcalfe

Venture Partner and Partner Emeritus

Pat Mulach

Associate

Amir Nashat

Executive Partner

Joe Noonan

Associate

Jeff Del Presto

Associate, Technology

Connor Ryan

Associate, Technology

Amy Schulman

Managing Partner

Gary Swart

Partner

Sharif Vakili

Associate

Jim Weinstein

Entrepreneur Partner

Bryce Youngren

Managing Partner

Joanna Zesiger

Controller

Past deals in Health Care

Nomad Health

Venture Round in 2022
Nomad Health, Inc. operates an online marketplace that enables users to find freelance and permanent clinical work in the United States. Its market place enables doctors to search for jobs by location, pay rate, medical facility, and more; and healthcare facilities to find doctors. The company was incorporated in 2015 and is based in New York, New York.

Nomad Health

Series D in 2021
Nomad Health, Inc. operates an online marketplace that enables users to find freelance and permanent clinical work in the United States. Its market place enables doctors to search for jobs by location, pay rate, medical facility, and more; and healthcare facilities to find doctors. The company was incorporated in 2015 and is based in New York, New York.

ByHeart

Series B in 2021
ByHeart, Inc. is an infant and baby nutrition company focused on developing products that support various aspects of children's health, including immune, microbiome, cognitive, and digestive health. Established in 2016 and headquartered in New York, the company operates with facilities in Pennsylvania. ByHeart aims to translate advanced nutrition science and breastmilk research into innovative foods and formulas, prioritizing natural ingredients and small-batch production to ensure quality. The company's commitment to promoting healthy growth and providing peace of mind for parents distinguishes it in the infant nutrition market.

OM1

Series D in 2021
OM1 (formerly Better Outcomes) is a digital health company focused on solving the problem of determining and understanding the true results of healthcare. We believe that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. We leverage a state-of-the-art technology platform, a world-class team of scientists, clinical experts and software engineers, and a committed network of organizations to create a new standard for health outcomes information.

Wellthy

Series B in 2021
Wellthy, Inc. is a family care concierge service based in New York, established in 2014. The company specializes in assisting individuals and families in managing the complexities of care for chronically ill, aging, or disabled loved ones. Wellthy connects families with dedicated Care Coordinators who help navigate the logistical and administrative tasks associated with caregiving. Their platform enables families to track appointments, organize tasks, store important documents, and maintain communication. Wellthy addresses various needs beyond medical care, including legal, financial, housing, and emotional support. The service is designed to alleviate the burden of caregiving by taking on tasks such as making calls, scheduling appointments, and managing paperwork. Additionally, Wellthy partners with employers to offer a compassionate and scalable solution to support families dealing with aging-related issues, childcare, special needs, and other ongoing care challenges.

Thirty Madison

Series C in 2021
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.

Cohere Health

Series B in 2021
Cohere Health, Inc., founded in 2019 and headquartered in Boston, Massachusetts, develops a software platform aimed at enhancing collaboration among healthcare stakeholders. The company focuses on improving the patient journey by creating a user-friendly experience for patients, healthcare providers, and health plans. Its mission includes increasing the quality of care, reducing overall healthcare costs, and fostering transparency throughout the patient care process. By leveraging technology, Cohere Health seeks to address the complexities of healthcare delivery, ultimately benefiting all parties involved.

Tausight

Series A in 2021
Tausight, Inc. develops a software for reducing healthcare cyber incidents of patient data theft. It serves chief information officer of health care sector. Tausight was founded in 2018 and is based in Sudbury, Massachusetts with additional office in San Francisco, California.

Folx Health

Series A in 2021
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

Sesh

Seed Round in 2020
Sesh Therapy Incorporated is a mental health company that delivers online group support through its mobile application. Founded in 2020 and headquartered in San Francisco, California, Sesh provides a range of sessions led by qualified mental health professionals, making mental healthcare more accessible and affordable compared to traditional therapy appointments. The platform aims to connect individuals seeking support in a collaborative environment, enhancing the overall mental health experience.

FidoCure

Series A in 2020
The One Health Company is a social impact company that brings precision medicine, used in humans, to dogs with cancer. It started by offering dogs with cancer access to cutting edge human clinical trials at no cost. Then, they created FidoCure directly for veterinarians and pet parents to offer treatment options to more dogs across the country. The company built partnerships with the world's top cancer researchers and a network of 111 of the best veterinary hospitals.

Keeps

Series B in 2020
2 out of 3 men will start to lose their hair by the age of 35 - but the earlier you take action, the more hair you keep. Keeps is a full-service healthcare company focused exclusively on helping men keep their hair. From expert diagnosis to affordable treatment, patient support to education, Keeps provides a regimen specific to each customer's condition through a seamless digital experience, allowing men to manage hair loss from start to finish. Keeps’ licensed physicians review each customer's information in order to identify and prescribe a unique treatment plan of FDA-approved products, and we sell them at half the price customers would pay at their local pharmacy. With Keeps, customers receive exactly what they need, and nothing they don’t. Keeps is the first brand from Thirty Madison, which is rebuilding the healthcare experience for the modern consumer.

Thirty Madison

Series B in 2020
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.

Foresight Mental Health

Series A in 2020
Foresight is a technology-enabled psychiatry and therapy services company. We directly employ psychiatrists, therapists, psychiatric nurse practitioners to treat patients in our offices. Our team of software and biomedical engineers create technology alongside our providers to revolutionize the care we provide.

Folx Health

Venture Round in 2020
Folx Health is a digital health services platform that builds a medical service marketplace tailored towards the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typically marginalized in traditional health settings. The startup focuses on providing patients gender-affirming hormone therapy, sexual health, and family creation services. Other services include erectile dysfunction treatment, PrEP, and STI testing. The company was founded by Agneta Breitenstein in 2019 in Boston, Massachusets.

ByHeart

Series A in 2020
ByHeart, Inc. is an infant and baby nutrition company focused on developing products that support various aspects of children's health, including immune, microbiome, cognitive, and digestive health. Established in 2016 and headquartered in New York, the company operates with facilities in Pennsylvania. ByHeart aims to translate advanced nutrition science and breastmilk research into innovative foods and formulas, prioritizing natural ingredients and small-batch production to ensure quality. The company's commitment to promoting healthy growth and providing peace of mind for parents distinguishes it in the infant nutrition market.

Iora Health

Series F in 2020
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

OM1

Series C in 2019
OM1 (formerly Better Outcomes) is a digital health company focused on solving the problem of determining and understanding the true results of healthcare. We believe that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. We leverage a state-of-the-art technology platform, a world-class team of scientists, clinical experts and software engineers, and a committed network of organizations to create a new standard for health outcomes information.

Nomad Health

Series C in 2019
Nomad Health, Inc. operates an online marketplace that enables users to find freelance and permanent clinical work in the United States. Its market place enables doctors to search for jobs by location, pay rate, medical facility, and more; and healthcare facilities to find doctors. The company was incorporated in 2015 and is based in New York, New York.

Ajax Health

Series C in 2019
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.

Quartet Health

Series D in 2019
Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Ajax Health

Series C in 2019
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.

Africa Healthcare Network

Series A in 2019
Africa Healthcare Network (AHN) has pioneered the first dialysis chain in Sub-Saharan Africa, aimed at delivering affordable, high-quality dialysis services for patients suffering from Acute Kidney Injury and End-Stage Renal Disease. In a region where existing facilities are limited and often charge exorbitant fees, AHN addresses the critical shortage of accessible dialysis care. The organization leverages its technical expertise and practical experience to establish well-equipped centers, while also focusing on training healthcare professionals to enhance service delivery. As Chronic Kidney Disease and related health issues rise due to urbanization and lifestyle changes, AHN's model prioritizes operational efficiency and cost-effective sourcing of medical supplies, thereby reducing treatment costs for patients. Operating in Rwanda, Tanzania, and Kenya, AHN is committed to increasing access to life-saving dialysis care, ultimately improving patient outcomes while ensuring financial sustainability.

KenSci

Series B in 2019
KenSci's machine learning powered risk prediction platform helps healthcare providers and payers intervene early by identifying clinical, financial and operational risk to save costs and lives. KenSci's platform is engineered to ingest, transform and integrate healthcare data across clinical, claims, and patient-generated sources. With a library of pre-built models and modular solutions, KenSci's machine learning platform to integrates into existing workflows allowing health systems to better identify utilization, variation and improve hospital operations. With Explainable AI models for healthcare, KenSci is making risk-based prediction more efficient and accountable.

Wellthy

Series A in 2019
Wellthy, Inc. is a family care concierge service based in New York, established in 2014. The company specializes in assisting individuals and families in managing the complexities of care for chronically ill, aging, or disabled loved ones. Wellthy connects families with dedicated Care Coordinators who help navigate the logistical and administrative tasks associated with caregiving. Their platform enables families to track appointments, organize tasks, store important documents, and maintain communication. Wellthy addresses various needs beyond medical care, including legal, financial, housing, and emotional support. The service is designed to alleviate the burden of caregiving by taking on tasks such as making calls, scheduling appointments, and managing paperwork. Additionally, Wellthy partners with employers to offer a compassionate and scalable solution to support families dealing with aging-related issues, childcare, special needs, and other ongoing care challenges.

Ajax Health

Series B in 2018
Ajax Health is a private equity and venture capital firm established in 2017, with its headquarters in Menlo Park, California, and an additional office in New York City. The firm specializes in investing across all stages of a company's lifecycle, focusing on innovative medical device companies, healthcare services, digital health, biotechnology, and healthcare IT. Ajax Health aims to accelerate medical innovation by providing both capital and strategic capabilities to address significant challenges in healthcare. Through its investments, the firm seeks to foster advancements in healthcare technologies and improve patient outcomes.

OM1

Series B in 2018
OM1 (formerly Better Outcomes) is a digital health company focused on solving the problem of determining and understanding the true results of healthcare. We believe that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. We leverage a state-of-the-art technology platform, a world-class team of scientists, clinical experts and software engineers, and a committed network of organizations to create a new standard for health outcomes information.

Iora Health

Series E in 2018
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

Nomad Health

Series B in 2018
Nomad Health, Inc. operates an online marketplace that enables users to find freelance and permanent clinical work in the United States. Its market place enables doctors to search for jobs by location, pay rate, medical facility, and more; and healthcare facilities to find doctors. The company was incorporated in 2015 and is based in New York, New York.

Quartet Health

Series C in 2018
Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Africa Healthcare Network

Venture Round in 2016
Africa Healthcare Network (AHN) has pioneered the first dialysis chain in Sub-Saharan Africa, aimed at delivering affordable, high-quality dialysis services for patients suffering from Acute Kidney Injury and End-Stage Renal Disease. In a region where existing facilities are limited and often charge exorbitant fees, AHN addresses the critical shortage of accessible dialysis care. The organization leverages its technical expertise and practical experience to establish well-equipped centers, while also focusing on training healthcare professionals to enhance service delivery. As Chronic Kidney Disease and related health issues rise due to urbanization and lifestyle changes, AHN's model prioritizes operational efficiency and cost-effective sourcing of medical supplies, thereby reducing treatment costs for patients. Operating in Rwanda, Tanzania, and Kenya, AHN is committed to increasing access to life-saving dialysis care, ultimately improving patient outcomes while ensuring financial sustainability.

Iora Health

Series D in 2016
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

US HealthVest

Series B in 2016
US HealthVest is an innovative behavioral healthcare firm that has redefined the psychiatric hospital space. De novo strategies and acquisitions of operating facilities with unrealized potential are the core of the US HealthVest business model. Each facility is structured to offer multiple service lines in order to serve the needs of specific patient population groups. The senior management team of US HealthVest has successfully built psychiatric hospital businesses which were acquired by public companies. Ascend Health was founded by Richard Kresch, M.D. in 2005 and was one of the largest private psychiatric hospital providers with nine freestanding facilities and nearly 900 beds. Ascend Health was sold to Universal Health Services (NYSE: UHS) in 2012. The predecessor company, Heartland Health Developments, also focused on psychiatric care and was sold to Psychiatric Solutions in 2004.

Quartet Health

Series B in 2016
Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Arsenal Medical

Venture Round in 2015
Arsenal Medical, Inc., a platform technology company, develops polymer based foams and fibers for the treatment of vascular diseases. It develops in-situ forming foams to provide local therapy for acute hemorrhage and other critical clinical conditions, including vascular injury and repair. The company also provides AxioCore, a core-sheath nanofiber and microfiber technology constructed from known biomaterials, which is used for cell integration and tissue regeneration enabling controlled delivery of a range of biologics and therapeutics. Arsenal Medical, Inc. was founded in 2005 and is based in Watertown, Massachusetts.

Quartet Health

Series A in 2015
Quartet Health, Inc. develops and operates a cloud based platform that allows communication and collaboration between medical providers with behavioral health providers for patient care. Its platform works with health plans and health systems to provide actionable population insights and reports on behavioral health conditions to improve patient outcomes, as well as provides tools for patient self-management. The company was founded in 2014 and is based in New York, New York.

Iora Health

Series C in 2015
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

Strata Health

Venture Round in 2014
Strata Health leverages technology to achieve dramatic patient flow improvement within health systems. Our clients say they’ve entrusted us with the job of creating patient flow solutions that achieve real and dramatic benefits for patients, their families and the world’s devoted front line caregivers. Operational in Canada and the UK, Strata Health is a privately held Canadian corporation. It is comprised of professionals with empathy for those who need care and intense respect for those who devote themselves to caring for others.

Iora Health

Series B in 2013
Iora Health, Inc. operates a primary care healthcare system in the United States, focusing on providing comprehensive care to patients, particularly college employees and their adult dependents. Founded in 2010 and headquartered in Boston, Massachusetts, the organization emphasizes personalized care by assigning each patient a dedicated physician and a health coach. This team facilitates continuous support through various communication methods, including email, text, and video, alongside in-person visits. Iora Health also offers educational programs, such as group visits, aimed at empowering patients to manage their health effectively and achieve their health goals. The company is dedicated to removing barriers in the healthcare system, ensuring that patients receive the attention and resources they need to navigate their health journeys successfully.

US HealthVest

Series A in 2013
US HealthVest is an innovative behavioral healthcare firm that has redefined the psychiatric hospital space. De novo strategies and acquisitions of operating facilities with unrealized potential are the core of the US HealthVest business model. Each facility is structured to offer multiple service lines in order to serve the needs of specific patient population groups. The senior management team of US HealthVest has successfully built psychiatric hospital businesses which were acquired by public companies. Ascend Health was founded by Richard Kresch, M.D. in 2005 and was one of the largest private psychiatric hospital providers with nine freestanding facilities and nearly 900 beds. Ascend Health was sold to Universal Health Services (NYSE: UHS) in 2012. The predecessor company, Heartland Health Developments, also focused on psychiatric care and was sold to Psychiatric Solutions in 2004.

Arsenal Medical

Debt Financing in 2011
Arsenal Medical, Inc., a platform technology company, develops polymer based foams and fibers for the treatment of vascular diseases. It develops in-situ forming foams to provide local therapy for acute hemorrhage and other critical clinical conditions, including vascular injury and repair. The company also provides AxioCore, a core-sheath nanofiber and microfiber technology constructed from known biomaterials, which is used for cell integration and tissue regeneration enabling controlled delivery of a range of biologics and therapeutics. Arsenal Medical, Inc. was founded in 2005 and is based in Watertown, Massachusetts.

Phreesia

Series D in 2010
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Respicardia

Series C in 2010
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.

Phreesia

Series D in 2010
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Arsenal Medical

Venture Round in 2010
Arsenal Medical, Inc., a platform technology company, develops polymer based foams and fibers for the treatment of vascular diseases. It develops in-situ forming foams to provide local therapy for acute hemorrhage and other critical clinical conditions, including vascular injury and repair. The company also provides AxioCore, a core-sheath nanofiber and microfiber technology constructed from known biomaterials, which is used for cell integration and tissue regeneration enabling controlled delivery of a range of biologics and therapeutics. Arsenal Medical, Inc. was founded in 2005 and is based in Watertown, Massachusetts.

Phytel

Venture Round in 2010
Phytel, Inc. is a provider of population health management software solutions designed to facilitate coordinated care for patients within healthcare organizations. Founded in 1996 and headquartered in Dallas, Texas, Phytel serves a diverse range of clients, including accountable care organizations, physician practices, hospitals, health systems, integrated delivery networks, and community health centers. The company specializes in disease management and preventive care protocols, which help identify and notify patients who are non-compliant with recommended healthcare actions. Additionally, Phytel maintains essential prescription, lab, and clinical data to support health and disease management efforts. The company also offers systems integration, application development, and reporting services to enhance operational efficiency in healthcare delivery.

MicroCHIPS

Venture Round in 2010
Microchips Biotech, Inc. is dedicated to improving the lives of patients by revolutionizing drug delivery. Our proprietary microchip-based implant can store and release precise doses of drugs over months and years. The implant, which is placed under the skin by a trained physician during a simple office procedure using local anesthesia, can be wirelessly activated or deactivated by a physician or patient, without requiring removal. In addition, physicians can wirelessly modify the frequency or dose of the drug to meet the individual needs of each patient.

Phreesia

Series C in 2009
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

CodeRyte

Series D in 2008
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.

Respicardia

Series B in 2008
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.

Imprivata

Series C in 2008
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

HealthCentral

Post in 2008
HealthCentral operates a network of over 30 websites focused on various health conditions, wellness, and general health topics, including allergy, bipolar disorder, cholesterol, and high blood pressure. These platforms offer users access to medical news, videos, and community interactions, as well as reputable resources like Harvard Health Publications. In addition to its online presence, HealthCentral produces the nationally syndicated television show "Medical Breakthroughs with Dr. Dean Edell." Founded in 1999 and based in Arlington, Virginia, HealthCentral was originally known as ChoiceMedia, Inc. The company has undergone significant investment changes since its acquisition in 2005 by various firms, including Polaris Venture Partners and The Carlyle Group, with a notable minority stake acquired by IAC. HealthCentral competes with other health information providers such as WebMD and RevolutionHealth.

Arsenal Medical

Series B in 2007
Arsenal Medical, Inc., a platform technology company, develops polymer based foams and fibers for the treatment of vascular diseases. It develops in-situ forming foams to provide local therapy for acute hemorrhage and other critical clinical conditions, including vascular injury and repair. The company also provides AxioCore, a core-sheath nanofiber and microfiber technology constructed from known biomaterials, which is used for cell integration and tissue regeneration enabling controlled delivery of a range of biologics and therapeutics. Arsenal Medical, Inc. was founded in 2005 and is based in Watertown, Massachusetts.

Phreesia

Series B in 2007
Phreesia is a privately held company specializing in patient check-in solutions for healthcare organizations. The company offers a wireless touch screen device known as the PhreesiaPad, which automates the patient check-in process by securely collecting personal health information in compliance with HIPAA regulations. This system integrates seamlessly with existing electronic medical records (EMRs) and does not disrupt physician workflows. Phreesia enhances the patient experience by preparing individuals for appointments, providing relevant health education, and allowing them to verify previously recorded information. Additionally, Phreesia's software solutions improve the operational and financial performance of healthcare providers by managing various aspects of patient access, registration, payments, and clinical support. The company is supported by a Medical Advisory Board and has initiated patient care initiatives focused on wellness and disease prevention, having secured $13.25 million in funding to date.

Solace Pharmaceuticals

Series A in 2007
Solace Pharmaceuticals, a Boston based drug company focused on therapeutics for chronic pain.

Ascend Health

Series B in 2007
Ascend Health Corporation is a behavioral healthcare provider, offering a full range of inpatient and day hospital services to children, adolescents, adults and seniors. They focus on personal choice and specialized care. Their facilities provide high quality care by working closely to integrate their services with the healthcare system in each local community.

CodeRyte

Series C in 2006
CodeRyte is the premier provider of computer-assisted coding and clinical data extraction solutions for the healthcare industry. Their sophisticated technology streamlines the coding process and identifies clinically relevant information from medical records. Their clients secure their rightful reimbursement, enhance compliance and efficiency through computer-assisted coding. CodeRyte's data extraction solutions analyze the language of physician narratives and elevate previously undiscovered data for critical treatment and business decisions. Many of the nation's top physician practices, billing companies and academic medical centers rely on CodeRyte as the centerpiece of their coding and data mining operations.

Imprivata

Series B in 2006
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

Imprivata

Series A in 2005
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

Life Line Screening

Private Equity Round in 2005
Life Line Screening of America, Ltd. provides community-based preventive health screening services in the United States and the United Kingdom. The company offers ultrasound, finger-stick blood, and limited electrocardiograph screenings. It provides screenings for stroke/carotid artery disease, abdominal aortic aneurysm, stroke/atrial fibrillation, peripheral arterial disease, heart disease risk, osteoporosis risk, elevated C-reactive protein, high cholesterol, type 2 diabetes, elevated liver enzymes, and chronic kidney disease. The company was founded in 1993 and is headquartered in Austin, Texas.

The Center from Health Promotion

Venture Round in 2003
The Center for Health Promotion Inc. delivers tobacco cessation and weight management services to customers nationwide. As an operating unit of Group Health Cooperative (Seattle) for almost 20 years, CHP developed the telephone-based Free & Clear program and established itself a national leader in tobacco cessation. Today CHP continues to deliver tobacco cessation services through health plans, businesses and labor organizations around the country. CHP also provides phone-based tobacco cessation services to residents of Georgia, Maine, Minnesota, Oklahoma, Oregon, Utah, Washington and Wisconsin through contracts with state agencies or coalitions. The company is actively engaged in research trials with major research centers including The Stanford Research Institute in Menlo Park, Calif., the Center for Health Research in Portland, Ore., and the Fred Hutchison Cancer Research Center and Group Health's Center for Health Studies, both in Seattle. This active research is undertaken to help improve CHP's services to smokers and increase scientific understanding of this key health issue.

Imprivata

Series A in 2002
Imprivata, Inc. specializes in information technology security and identity solutions tailored for the healthcare sector, operating primarily in the United States and the United Kingdom. The company offers a comprehensive security and identity platform that addresses critical security and compliance challenges faced by healthcare organizations. Its key products include Imprivata OneSign, which provides integrated enterprise single sign-on and authentication management; Imprivata Cortext, a secure communications platform for compliant SMS messaging; and Imprivata Confirm ID, which streamlines provider identity proofing and enforces two-factor authentication. Additionally, Imprivata PatientSecure enhances patient safety and operational efficiency by reducing duplicate medical records, while EPCS Ready supports compliance with electronic prescription regulations. Founded in 2001 and headquartered in Lexington, Massachusetts, Imprivata also offers professional services, customer support, and has a collaboration agreement with ICU Medical to ensure the security of medical devices.

Sentillion

Series C in 2001
Sentillion, Inc. offers identity and access management technology solutions for caregivers in hospitals and healthcare organizations in North America and the United Kingdom. The company provides solutions for sign-on, user provisioning, clinical workstations, and virtualized remote access. The company offers expreSSO that delivers transparent single sign-on in existing workflows; Bridges, which provides a mechanism for interfacing to applications; and proVision that alters, disables, and terminates access to systems and applications. It also offers Vergence, which unifies single sign-on, single patient selection, and authentication services in clinical workstation solution that enables caregivers to access and navigate between the myriad of clinical and business applications. In addition, it offers vThere, which enables to manage clinicians and staff, such as medical transcriptionists, remote physicians, contractors, and temporarily displaced employees; and IdMPOWER that enables to accelerate the process of incorporating applications and information systems in the company's environment. The company offers implementation services, comprising project planning, installation, training, integrated testing, and deployment; and technical support services, including toll-free telephone support, trouble-shooting, and operational support. Sentillion, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Sentillion

Series B in 2000
Sentillion, Inc. offers identity and access management technology solutions for caregivers in hospitals and healthcare organizations in North America and the United Kingdom. The company provides solutions for sign-on, user provisioning, clinical workstations, and virtualized remote access. The company offers expreSSO that delivers transparent single sign-on in existing workflows; Bridges, which provides a mechanism for interfacing to applications; and proVision that alters, disables, and terminates access to systems and applications. It also offers Vergence, which unifies single sign-on, single patient selection, and authentication services in clinical workstation solution that enables caregivers to access and navigate between the myriad of clinical and business applications. In addition, it offers vThere, which enables to manage clinicians and staff, such as medical transcriptionists, remote physicians, contractors, and temporarily displaced employees; and IdMPOWER that enables to accelerate the process of incorporating applications and information systems in the company's environment. The company offers implementation services, comprising project planning, installation, training, integrated testing, and deployment; and technical support services, including toll-free telephone support, trouble-shooting, and operational support. Sentillion, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Esurg.com

Series B in 2000
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.

Accordant Health Services

Venture Round in 2000
Accordant provides its program members with healthcare advice. The service focuses on delivering support for patients with rare, chronic diseases. Its care management solutions comprise of tools and resources of professionals in the healthcare sector. The service also delivers care management services for rare diseases which include health plans, employers, and third party administrators. Accordant is a subsidiary of CVS Caremark. It was founded by Steve Schelhammer and is headquartered in Greensboro, North Carolina.

Esurg.com

Series A in 1999
Esurg.com, the most comprehensive and trusted online source for medical, surgical and pharmaceutical supplies and information. They designed Their Web site for the growing number of physician practices and clinics working outside traditional hospital settings — to give them an edge in the increasingly complex business of medicine.

Sentillion

Series A in 1999
Sentillion, Inc. offers identity and access management technology solutions for caregivers in hospitals and healthcare organizations in North America and the United Kingdom. The company provides solutions for sign-on, user provisioning, clinical workstations, and virtualized remote access. The company offers expreSSO that delivers transparent single sign-on in existing workflows; Bridges, which provides a mechanism for interfacing to applications; and proVision that alters, disables, and terminates access to systems and applications. It also offers Vergence, which unifies single sign-on, single patient selection, and authentication services in clinical workstation solution that enables caregivers to access and navigate between the myriad of clinical and business applications. In addition, it offers vThere, which enables to manage clinicians and staff, such as medical transcriptionists, remote physicians, contractors, and temporarily displaced employees; and IdMPOWER that enables to accelerate the process of incorporating applications and information systems in the company's environment. The company offers implementation services, comprising project planning, installation, training, integrated testing, and deployment; and technical support services, including toll-free telephone support, trouble-shooting, and operational support. Sentillion, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.